PMCB · Forms 3, 4, 5
Insider trades at PharmaCyte Biotech, Inc.
No open-market insider buys or sells at PharmaCyte Biotech, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for PharmaCyte Biotech, Inc. (PMCB) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for PharmaCyte Biotech, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Robert Weinstein | Director | Options or other derivatives | Form 4 | ||||
| Wayne Remell Walker | Director | Options or other derivatives | Form 4 | ||||
| Jonathan Schechter | Director | Options or other derivatives | Form 4 | ||||
| Michael M Abecassis | Director | Options or other derivatives | Form 4 | ||||
| PharmaCyte Biotech, Inc. | 10% owner | Options or other derivatives | Form 4 | ||||
| Joshua Silverman | CEO and President | Buy | 40,000 | $0.83 | $33K | Form 4 | |
| Jonathan Schechter | Director | Buy | 20,000 | $0.84 | $17K | Form 4 | |
| Joshua Silverman | CEO and President | Buy | 30,000 | $0.79 | $24K | Form 4 | |
| Jonathan Schechter | Director | Buy | 20,000 | $0.79 | $16K | Form 4 | |
| Joshua Silverman | CEO and President | Buy | 30,000 | $0.78 | $23K | Form 4 | |
| Jonathan Schechter | Director | Buy | 20,000 | $0.78 | $16K | Form 4 | |
| Robert Weinstein | Director | Award | 75,000 | Form 4 | |||
| Robert Weinstein | Director | Tax withholding | 33,750 | $1.02 | $34K | Form 4 | |
| Wayne Remell Walker | Director | Award | 37,500 | Form 4 | |||
| Wayne Remell Walker | Director | Tax withholding | 16,875 | $1.02 | $17K | Form 4 | |
| Joshua Silverman | CEO and President | Award | 575,000 | Form 4 | |||
| Joshua Silverman | CEO and President | Tax withholding | 258,750 | $1.02 | $264K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.